% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hussein:817964,
author = {Hussein, Amr and Furth, Christian and Schönberger, Stefan
and Hundsdoerfer, Patrick and Steffen, Ingo and Amthauer,
Holger and Müller, Hans-Wilhelm and Hautzel, Hubertus},
title = {{FDG}-{PET} {R}esponse {P}rediction in {P}ediatric
{H}odgkin’s {L}ymphoma: {I}mpact of {M}etabolically
{D}efined {T}umor {V}olumes and {I}ndividualized {SUV}
{M}easurements on the {P}ositive {P}redictive {V}alue},
journal = {Cancers},
volume = {7},
number = {1},
issn = {2072-6694},
address = {Basel},
publisher = {MDPI},
reportid = {FZJ-2016-04543},
pages = {287 - 304},
year = {2015},
abstract = {Background: In pediatric Hodgkin’s lymphoma (pHL) early
response-to-therapy prediction is metabolically assessed by
(18)F-FDG PET carrying an excellent negative predictive
value (NPV) but an impaired positive predictive value (PPV).
Aim of this study was to improve the PPV while keeping the
optimal NPV. A comparison of different PET data analyses was
performed applying individualized standardized uptake values
(SUV), PET-derived metabolic tumor volume (MTV) and the
product of both parameters, termed total lesion glycolysis
(TLG); Methods: One-hundred-eight PET datasets (PET1, n =
54; PET2, n = 54) of 54 children were analysed by visual and
semi-quantitative means. SUVmax, SUVmean, MTV and TLG were
obtained the results of both PETs and the relative change
from PET1 to PET2 (Δ in $\%)$ were compared for their
capability of identifying responders and non-responders
using receiver operating characteristics (ROC)-curves. In
consideration of individual variations in noise and
contrasts levels all parameters were additionally obtained
after threshold correction to lean body mass and background;
Results: All semi-quantitative SUV estimates obtained at
PET2 were significantly superior to the visual PET2
analysis. However, ΔSUVmax revealed the best results (area
under the curve, 0.92; p < 0.001; sensitivity $100\%;$
specificity $85.4\%;$ PPV $46.2\%;$ NPV $100\%;$ accuracy,
$87.0\%)$ but was not significantly superior to
SUVmax-estimation at PET2 and ΔTLGmax. Likewise, the lean
body mass and background individualization of the datasets
did not impove the results of the ROC analyses; Conclusions:
Sophisticated semi-quantitative PET measures in early
response assessment of pHL patients do not perform
significantly better than the previously proposed ΔSUVmax.
All analytical strategies failed to improve the impaired PPV
to a clinically acceptable level while preserving the
excellent NPV.},
cin = {KME / INM-4},
ddc = {610},
cid = {I:(DE-Juel1)KME-20110218 / I:(DE-Juel1)INM-4-20090406},
pnm = {573 - Neuroimaging (POF3-573)},
pid = {G:(DE-HGF)POF3-573},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:25635760},
UT = {WOS:000209951000010},
doi = {10.3390/cancers7010287},
url = {https://juser.fz-juelich.de/record/817964},
}